HomeOwner SearchCategory Search
Visit USCOMOLECULAR CANCER THERAPEUTICS [Published: 2008-08-22. Issue: vol. 7, no. 8, 08/01/2008]
Serial Registration
Copyright Title
MOLECULAR CANCER THERAPEUTICS [Published: 2008-08-22. Issue: vol. 7, no. 8, 08/01/2008]
Status
Published
on 15 Sept 2008
Year of Creation
2008
Copyright Claimant
American Association for Cancer Research
Registration Number
TX0006880632
on 15 Sept 2008Copyright Summary
The U.S. Copyright record (Registration Number: TX0006880632) dated 15 Sept 2008, pertains to an electronic file (eService) titled "MOLECULAR CANCER THERAPEUTICS [Published: 2008-08-22. Issue: vol. 7, no. 8, 08/01/2008]" created in 2008. The copyright holder is American Association for Cancer Research, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to American Association for Cancer Research.
Application Details
Registration Number
TX0006880632
Registration Date
9/15/2008
Year of Creation
2008
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
American Association for Cancer Research
First Publication Nation
United States
ISSN
1535-7163
Notes
Copyright Local Holdings: vol. 7, no. 8, 08/01/2008 Created 2008 Pub. 2008-08-22 Reg. 2008-09-16 TX0006880632 JOCO
Statements
Application Title Statement: MOLECULAR CANCER THERAPEUTICS
Author Statement: American Association for Cancer Research employer for hire Citizenship: United States Authorship: Collective work which may include text, editing, compilation, and contribution(s) in which copyright has been transferred to the claimant
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.